Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary Tuberculosis.

MLA

Kumar, Nathella P., et al. “Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary Tuberculosis.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 73, no. 9, Nov. 2021, pp. e3419–27. EBSCOhost, https://doi.org/10.1093/cid/ciaa1104.

APA

Kumar, N. P., Moideen, K., Nancy, A., Viswanathan, V., Thiruvengadam, K., Nair, D., Banurekha, V. V., Sivakumar, S., Hissar, S., Kornfeld, H., & Babu, S. (2021). Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary Tuberculosis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 73(9), e3419–e3427. https://doi.org/10.1093/cid/ciaa1104

Chicago

Kumar, Nathella P, Kadar Moideen, Arul Nancy, Vijay Viswanathan, Kannan Thiruvengadam, Dina Nair, Vaithilingam V Banurekha, et al. 2021. “Plasma Chemokines Are Baseline Predictors of Unfavorable Treatment Outcomes in Pulmonary Tuberculosis.” Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 73 (9): e3419–27. doi:10.1093/cid/ciaa1104.